Exogenous expression of TRAF3 enhanced the sensitivity of GBM to ferroptosis and effectively synergized with anti–programmed death–ligand 1 (anti–PD-L1) therapy in an orthotopic GBM model, indicating a promising therapeutic strategy for glioblastoma. The gene discussed is CD274; the disease is glioblastoma.